Dysmenorrhea: Risk factors in women with endometriosis

Women's Health

Volumn 4, Issue 4, 2008, Pages 399-411

  Liu, Xishi ^a,b   Guo, Sun Wei ^c  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Dysmenorrhea; Endometriosis; Risk factors; Severity; Statistical methodology

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA1;

ADENOMYOSIS; CELL DENSITY; CELLULAR DISTRIBUTION; COMORBIDITY; COPING BEHAVIOR; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; DYSMENORRHEA; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; FEMALE INFERTILITY; HISTOPATHOLOGY; HUMAN; NERVE CELL; PREVALENCE; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SOMATIZATION; SOMATOFORM DISORDER; TISSUE DISTRIBUTION; UTERUS SYNECHIA; VISUAL ANALOG SCALE;

DYSMENORRHEA; ENDOMETRIOSIS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LOGISTIC MODELS; OVARIAN DISEASES; PAIN MEASUREMENT; PELVIC PAIN; QUALITY OF LIFE; RESEARCH DESIGN; RISK FACTORS; SEVERITY OF ILLNESS INDEX; WOMEN'S HEALTH;

EID: 48649094883     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.4.4.399     Document Type: Review

References (72)

1. Pullon S, Reinken J, Sparrow M: Prevalence of dysmenorrhoea in Wellington women. N. Z. Med. J. 101(839), 52-54 (1988).
2. Zondervan KT, Yudkin PL, Vessey MP et al.: The community prevalence of chronic pelvic pain in women and associated illness behaviour. Br. J. Gen. Pract. 51(468), 541-547 (2001).
3. Weissman AM, Hart AJ, Hansen MD, Johnson SR: The natural history of primary dysmenorrhoea: a longitudinal study. BJOG 111(4), 345-352 (2004).
4. Patel V, Tanksale V, Sahasrabhojanre M, Gupte S, Nevrekar P: The burden and determinants of dysmenorrhoea: a population-based survey of 2262 women in Goa, India. BJOG 113(4), 453-463 (2006).
5. Latthe P, Latthe M, Say L, Gulmezoglu M, Khan KS: WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health 6, 177 (2006).
6. Howard FM: Laparoscopic evaluation and treatment of women with chronic pelvic pain. J. Am. Assoc. Gynecol. Laparosc. 1(4 Pt 1), 325-331 (1994).
7. Latthe P, Mignini L, Gray R, Hills R, Khan K: Factors predisposing women to chronic pelvic pain: systematic review. Br. Med. J. 332(7544), 749-755 (2006).
8. French L: Dysmenorrhea in adolescents: diagnosis and treatment. Paediatr. Drugs 10(1), 1-7 (2008).
9. Mathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF: Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet. Gynecol. 87(3), 321-327 (1996).
10. Guo SW, Wang Y: The prevalence of endometriosis in women with chronic pelvic pain. Gynecol. Obstet. Invest. 62(3), 121-130 (2006).
11. Fauconnier A, Chapron C, Dubuisson JB, Vieira M, Dousset B, Breart G: Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis. Fertil. Steril. 78(4), 719-726 (2002).
12. Olive DL: Optimizing gonadotropin-releasing hormone agonist therapy in women with endometriosis. Treat. Endocrinol. 3(2), 83-89 (2004).
13. Giudice LC, Kan LC: Endometriosis. Lancet 364(9447), 1789-1799 (2004).
14. Olive DL, Pritts EA: The treatment of endometriosis: a review of the evidence. Ann. NY Acad. Sci. 955, 360-372; discussion 389-393, 396-406 (2002).
15. Farquhar CM: Extracts from the 'clinical evidence'. Endometriosis. Br. Med. J. 320(7247), 1449-1452 (2000).
16. Whiteside JL, Falcone T: Endometriosis-related pelvic pain: what is the evidence? Clin. Obstet. Gynecol. 46(4), 824-830 (2003).
17. Vercellini P: Endometriosis: what a pain it is. Semin. Reprod. Endocrinol. 15(3), 251-261 (1997).
18. Marana R, Muzii L, Caruana P, Dell' Acqua S, Mancuso S: Evaluation of the correlation between endometriosis extent, age of the patients and associated symptomatology. Acta Eur. Fertil. 22(4), 209-212 (1991).
19. Fedele L, Parazzini F, Bianchi S, Arcaini L, Candiani CB: Stage and localization of pelvic endometriosis and pain. Fertil. Steril. 53(1), 155-158 (1990).
20. Fedele L, Bianchi S, Bocciolone L, Di Nola G, Parazzini F: Pain symptoms associated with endometriosis. Obstet. Gynecol. 79(5 Pt 1), 767-769 (1992).
21. Muzii L, Marana R, Pedulla S, Catalano GF, Mancuso S: Correlation between endometriosis-associated dysmenorrhea and the presence of typical or atypical lesions. Fertil. Steril. 68(1), 19-22 (1997).
22. Stratton P, Sinaii N, Segars J et al.: Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial. Obstet. Gynecol. 111(1) 88-96 (2008).
23. Momoeda M, Taketani Y, Terakawa N et al.: Is endometriosis really associated with pain? Gynecol. Obstet. Invest. 54(Suppl. 1), 18-21; discussion 21-23 (2002).
24. Chopin N, Ballester M, Borghese B et al.: Relation between severity of dysmenorrhea and endometrioma. Acta Obstet. Gynecol. Scand. 85(11), 1375-1380 (2006).
25. Leng JH, Lang JH, Dai Y, Li HJ, Li XY: [Relationship between pain symptoms and clinico-pathological features of pelvic endometriosis]. Zhonghua Fu Chan Ke Za Zhi 42(3), 165-168 (2007).
26. Liu XS, Yuan L, Wang YD, Shen FH, Guo SW: Risk factors for dysmenorrhea and its severity in women with ovarian endometriomas. Gynecol. Obstet. Invest. 66, 169-177 (2008).
27. Chapron C, Fauconnier A, Dubuisson JB, Barakat H, Vieira M, Breart G: Deep infiltrating endometriosis: relation between severity of dysmenorrhoea and extent of disease. Hum. Reprod. 18(4), 760-766 (2003).
28. Porpora MG, Koninckx PR, Piazze J, Natili M, Colagrande S, Cosmi EV: Correlation between endometriosis and pelvic pain. J. Am. Assoc. Gynecol. Laparosc. 6(4), 429-434 (1999).
29. Mehmud G, Akhtar T, Sadia S: Endometriosis: frequency and correlation between symptomatology and disease stage. J. Coll. Physicians Surg. Pak. 17(4), 199-202 (2007).
30. Milingos S, Protopapas A, Kallipolitis G et al.: Endometriosis in patients with chronic pelvic pain: is staging predictive of the efficacy of laparoscopic surgery in pain relief? Gynecol. Obstet. Invest. 62(1), 48-54 (2006).
31. Tulande T, Chen MF, Al-Took S, Watkin K: A study of nerve fibers and histopathology of postsurgical, postinfectious, and endometriosis-related adhesions. Obstet. Gynecol. 92(5), 766-769 (1998).
32. Sulaiman H, Gabella G, Davis MC et al.: Presence and distribution of sensory nerve fibers in human peritoneal adhesions. Ann. Surg. 234(2), 256-261 (2001).
33. Al-Fozan H, Bakare S, Chen MF, Tulandi T: Nerve fibers in ovarian dermoid cysts and endometriomas. Fertil. Steril. 82(1), 230-231 (2004).
34. Koninckx PR, Meuleman C, Demeyere S, Lesaffre E, Cornillie FJ: Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil. Steril. 55(4), 759-765 (1991).
35. Anaf V, Simon P, El Nakadi I et al.: Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum. Reprod. 15(8), 1744-1750 (2000).
36. Anaf V, Simon P, El Nakadi I et al.: Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis. Hum. Reprod. 17(7), 1895-1900 (2002).
37. Kunz G, Beil D, Huppert P, Noe M, Kissler S, Leyendecker G: Adenomyosis in endometriosis - prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum. Reprod. 20(8), 2309-1236 (2005).
38. Kunz G, Herbertz M, Beil D, Huppert P, Leyendecker G: Adenomyosis as a disorder of the early and late human reproductive period. Reprod. Biomed. Online 15(6), 681-685 (2007).
39. Benson RC, Sneeden VD: Adenomyosis: a reappraisal of symptomatology. Am. J. Obstet. Gynecol. 76(5), 1044-1057; discussion 1057-1061 (1958).
40. Kissler S, Zangos S, Kohl J et al.: Duration of dysmenorrhoea and extent of adenomyosis visualised by magnetic resonance imaging. Eur. J. Obstet. Gynecol. Reprod. Biol. 137(2), 204-209 (2008).
41. Parker JD, Leondires M, Sinaii N, Premkumar A, Nieman LK, Stratton P: Persistence of dysmenorrhea and nonmenstrual pain after optimal endometriosis surgery may indicate adenomyosis. Fertil. Steril. 86(3), 711-715 (2006).
42. Rapkin AJ, Mayer EA: Gastroenterologic causes of chronic pelvic pain. Obstet. Gynecol. Clin. North Am. 20(4), 663-683 (1993).
43. Perper MM, Nezhat F, Goldstein H, Nezhat CH, Nezhat C: Dysmenorrhea is related to the number of implants in endometriosis patients. Fertil. Steril. 63(3), 500-503 (1995).
44. Vercellini P, Fedele L, Aimi G, Pietropaolo G, Consonni D, Crosignani PG: Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients. Hum. Reprod. 22(1), 266-271 (2007).
45. Ananth CV, Kleinbaum DG: Regression models for ordinal responses: a review of methods and applications, Int. J. Fpidemiol. 26(6), 1323 -1333 (1997).
46. Kooperberg C, Bose S, Stone CJ: Polychotomous regression. J. Am. Stat. Assoc. 92, 117-127 (1997).
47. Kalblleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. Wiley, NY, USA (1980).
48. Merskey H, Bogduk N: Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms (2nd Edition). IASP Press, WA, USA (1994).
49. Lipowski ZJ: Somatization: the concept and its clinical application. Am. J. Psychiatry 145(11), 1358-1368 (1988).
50. Hardt J, Gerbershagen HU, Franke P: The symptom check-list, SCL-90-R: its use and characteristics in chronic pain patients. Eur. J. Pain 4(2), 137-148 (2000).
51. Kroenke K, Swindle R: Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother. Psychosom. 69(4), 205-215 (2000).
52. Rierdan J, Koff E: Premenarcheal predictors of the experience of menarche: a prospective study. J. Adolesc. Health Care 11 (5), 404-407 (1990).
53. Sigmon ST, Dorhofer DM, Rohan KJ, Boulard NE: The impact of anxiety sensitivity, bodily expectations, and cultural beliefs on menstrual symptom reporting: a test of the menstrual reactivity hypothesis. J. Anxiety Disord. 14(6), 615-633 (2000).
54. Goldstein-Ferber S, Granot M: The association between somatization and perceived ability: roles in dysmenorrhea among Israeli Arab adolescents. Psychosom. Med. 68(1), 136-142.(2006).
55. Granot M, Yarnitsky D, Itskovitz-Eldor J, Granovsky Y, Peer E, Zimmer EZ: Pain perception in women with dysmenorrhea. Obstet. Gynecol. 98(3), 407-411 (2001).
56. Bajaj P, Bajaj P, Madsen H, Arendt-Nielsen L: A comparison of modality-specific somatosensory changes during menstruation in dysmenorrheic and nondysmenorrheic women. Chin. J. Pain 18(3), 180-190 (2002).
57. Brinkert W, Dimcevski G, Arendt-Nielsen L, Drewes AM, Wilder-Smith OH: Dysmenorrhoea is associated with hypersensitivity in the sigmoid colon and rectum. Pain 132(Suppl. 1), S46-S51 (2007).
58. Bajaj P, Bajaj P, Madsen H, Arendt-Nielsen L: Endometriosis is associated with central sensitization: a psychophysical controlled study. J. Pain 4(7), 372-380 (2003).
59. Campbell JN, Meyer RA: Medianisms of neuropathic pain. Neuron 52(1), 77-92 (2006).
60. Cason AM, Samuelsen CL, Berkley KJ: Estrous changes in vaginal nociception in a rat model of endometriosis. Horm. Behav. 44(2), 123-131 (2003).
61. Berkley KJ, Rapkin AJ, Papka RE: The pains of endometriosis. Science 308(5728), 1587-1589 (2005).
62. Holmlund U: The experience of dysmenorrhea and its relationship to personality variables. Acta Psyrchiatr: Scand. 82(2), 182-187 (1990).
63. Gomibuchi H, Taketani Y, Doi M et al.: Is personality involved in the expression of dysmenorrhea in patients with endometriosis? Am. J. Obstet. Gynecol. 169(3), 723-725 (1993),
64. Whitehead WE, Crowell MD, Heller BR, Robinson JC, Schuster MM, Horn S: Modeling and reinforcement of the sick role during childhood predicts adult illness behavior. Psychosom. Med. 56(6), 541-550 (1994).
65. Walsh TM, LeBlanc L, McGrath PJ: Menstrual pain intensity, coping, and disability: the role of pain catastrophizing. Pain Med. 4(4), 352-361 (2003).
66. Proctor ML, Murphy PA, Pattison HM, Suckling J, Farquhar CM: Behavioural interventions for primary and secondary dysmenorrhoea. Cochrane Database Syst. Rev. Issue 3. Art. No.: CDO02248. DOI: 10. 1002/ 14651858.CDO02248.pub3 (2007).
67. Tamburro S, Canis M, Albuisson E, Dechelotte P, Darcha C, Mage G: Expression of transforming growth factor β1 in nerve fibers is related to dysmenorrhea and laparoscopic appearance of endometriotic implants. Fertil. Steril. 80(5), 1131-1136 (2003).
68. Uceyler N, Sommer C: Cytokine regulation in animal models of neuropathic pain and in human diseases. Neurosci. Lett. 437(3), 194-198 (2008).
69. Zhang X, Wen J, Deng L, Lin J: Decreased levels of peritoneal interleukin- 1 receptor antagonist in patients with endometriosis and disease-related dysmenorrhea. Fertil. Steril. 88(3), 594-599 (2007).
70. Ho HN, Wu MY. Yang YS: Peritoneal cellular immunity and endometriosis. Am. J. Reprod. Immunol. 38(6) 400-412 (1997).
71. Vercellini P, Trespidi L, De Giorgi O, Cortesi I, Parazzini F, Crosignani PG: Endometriosis and pelvic pain: relation to disease stage and localization. Fertil. Steril. 65(2), 299-304 (1996).
72. Vercellini P, Fedele L, Aimi G, Pietropaolo C, Consonni D, Crosignani PG: Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients. Hum. Reprod. 22(1), 266-271 (2007).